Literature DB >> 8713089

Activation of protein kinase C by lysophosphatidic acid: dependence on composition of phospholipid vesicles.

J J Sando1, O I Chertihin.   

Abstract

Lysophosphatidic acid (LPA) has attracted recent attention as a major serum-derived regulator implicated in responses to vascular injury and inflammation, in tumour invasiveness and in neuronal signalling and remodelling. Although the possibility of a specific G-protein-coupled LPA receptor protein has been suggested, characterization of such a receptor is lacking. Since LPA can activate protein kinase C (PKC) pathways in many cells and PKC activators mimic many LPA effects, the possibility of more direct LPA effects on PKC was investigated. Phosphatidylcholine (PC)/phosphatidylserine (PS)/diacylglycerol (DAG) lipid vesicles of defined acyl chain composition were used to activate the enzyme. At total concentrations of saturated PC/PS + DAG vesicles (2-3 mM) that provided maximal PKC activation, 1-10 mol % [18:1]-LPA led to a further approx. 2-fold activation of PKC alpha. At lower lipid concentrations, a greater increase was observed with LPA concentrations up to 16-20 mol %. Higher concentrations of LPA were inhibitory. The LPA activation of PKC was dependent on the presence of DAG, PS and Ca2+. [18:1]-Lysophosphatidylcholine produced similar PKC activation in PC/PS/DAG vesicles. [14:0]-LPA was less effective, and longer-chain saturated lysolipids were ineffective. In unsaturated PC/PS vesicles, very little to no effect of LPA was discernable. These results suggest that physiologically or pathologically relevant concentrations of LPA can contribute to PKC activation depending on the composition of the lipid membrane. We hypothesize that LPA may affect the formation of lipid domains that are recognized by the enzyme.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8713089      PMCID: PMC1217526          DOI: 10.1042/bj3170583

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

Review 1.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

2.  Suramin, an anti-cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2A.

Authors:  C E Hensey; D Boscoboinik; A Azzi
Journal:  FEBS Lett       Date:  1989-11-20       Impact factor: 4.124

3.  Potentiation of diacylglycerol-induced activation of protein kinase C by lysophospholipids. Subspecies difference.

Authors:  Y Sasaki; Y Asaoka; Y Nishizuka
Journal:  FEBS Lett       Date:  1993-03-29       Impact factor: 4.124

4.  LPA: a novel lipid mediator with diverse biological actions.

Authors:  W H Moolenaar
Journal:  Trends Cell Biol       Date:  1994-06       Impact factor: 20.808

5.  Differences in the regulation of endothelin-1- and lysophosphatidic-acid-stimulated Ins(1,4,5)P3 formation in rat-1 fibroblasts.

Authors:  R Plevin; E E MacNulty; S Palmer; M J Wakelam
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

6.  Phorbol ester and diacylglycerol induce protein phosphorylation at tyrosine.

Authors:  T Gilmore; G S Martin
Journal:  Nature       Date:  1983 Dec 1-7       Impact factor: 49.962

7.  Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin.

Authors:  E J van Corven; A van Rijswijk; K Jalink; R L van der Bend; W J van Blitterswijk; W H Moolenaar
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

Review 8.  Lipid mediators and protein kinase C activation for the intracellular signaling network.

Authors:  S Nakamura; Y Nishizuka
Journal:  J Biochem       Date:  1994-06       Impact factor: 3.387

9.  Activation and inhibition of protein kinase C isozymes alpha and beta by Gd3+.

Authors:  M C Maurer; C M Grisham; J J Sando
Journal:  Arch Biochem Biophys       Date:  1992-11-01       Impact factor: 4.013

10.  Lysophosphatidylcholine induces mast cell secretion and protein kinase C activation.

Authors:  D L Marquardt; L L Walker
Journal:  J Allergy Clin Immunol       Date:  1991-11       Impact factor: 10.793

View more
  14 in total

1.  Two-dimensional crystal structures of protein kinase C-delta, its regulatory domain, and the enzyme complexed with myelin basic protein.

Authors:  Alexander S Solodukhin; Heather L Caldwell; Julianne J Sando; Robert H Kretsinger
Journal:  Biophys J       Date:  2002-05       Impact factor: 4.033

2.  Roles of atypical protein kinase C in lysophosphatidic acid-induced type II adenylyl cyclase activation in RAW 264.7 macrophages.

Authors:  W W Lin; S H Chang; S M Wang
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

3.  Effects of dipalmitoylglycerol and fatty acids on membrane structure and protein kinase C activity.

Authors:  E M Goldberg; R Zidovetzki
Journal:  Biophys J       Date:  1997-11       Impact factor: 4.033

4.  Lipid lateral heterogeneity in phosphatidylcholine/phosphatidylserine/diacylglycerol vesicles and its influence on protein kinase C activation.

Authors:  A R Dibble; A K Hinderliter; J J Sando; R L Biltonen
Journal:  Biophys J       Date:  1996-10       Impact factor: 4.033

5.  Inhibition of isoflurane-induced increase of cell-surface redistribution and activity of glutamate transporter type 3 by serine 465 sequence-specific peptides.

Authors:  Yueming Huang; Liaoliao Li; Jacqueline M Washington; Xuebing Xu; Julianne J Sando; Daowei Lin; Zhiyi Zuo
Journal:  Eur J Pharmacol       Date:  2011-01-23       Impact factor: 4.432

6.  Influence of lipid on the structure and phosphorylation of protein kinase C alpha substrate peptides.

Authors:  B B Vinton; S L Wertz; J Jacob; J Steere; C M Grisham; D S Cafiso; J J Sando
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

7.  Regulation of ghrelin structure and membrane binding by phosphorylation.

Authors:  Eva Dehlin; Jianhua Liu; Samuel H Yun; Elizabeth Fox; Sandra Snyder; Cyrille Gineste; Leslie Willingham; Mario Geysen; Bruce D Gaylinn; Julianne J Sando
Journal:  Peptides       Date:  2008-02-13       Impact factor: 3.750

Review 8.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

9.  Gelsolin and functionally similar actin-binding proteins are regulated by lysophosphatidic acid.

Authors:  K Meerschaert; V De Corte; Y De Ville; J Vandekerckhove; J Gettemans
Journal:  EMBO J       Date:  1998-10-15       Impact factor: 11.598

10.  Differential effects of lysophosphatidic acid and phosphatidylinositol 4,5-bisphosphate on actin dynamics by direct association with the actin-binding protein villin.

Authors:  Alok Tomar; Sudeep P George; Sijo Mathew; Seema Khurana
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.